Mongolia is a hot spot for HBV and HCV

 Mongolia, a nation bordered by China and Russia, is known for vast, rugged expanses and nomadic culture. Its capital, Ulaanbaatar, centers around Chinggis Khaan (Genghis Khan) Square, named for the notorious founder of the 13th- and 14th-century Mongol Empire. The official language of Mongolia is Mongolian and population size is…

Read More

Tenofovir alafenamide for HBV Patients

We need to tenofovir alafenamide for HBV patients now in Iran! The US Food and Drug Administration has approved tenofovir alafenamide (TAF) 25 mg once daily, for treatment of adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Tenofovir disoproxil fumarate (TDF) has potent antiviral activity in…

Read More

Hepatitis C vaccine development shows progress but scientific barriers remain

12 September 2016 An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and incomplete natural immunity, according to presentations at the 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) last…

Read More

Jordan is low endemicity for HCV infection in Middle East Region

Jordan is low endemicity for HCV infection in Middle East Region   Seroprevalence rates of transfusion-transmitted infections among blood donors in Jordan. By Souan L in J Infect Dev Ctries. 2016 Apr 28;10(4):377-83 Abstract INTRODUCTION: Statistics on the prevalence of donor screening for hepatitis B surface antigen (HBsAg) and anti-hepatitis…

Read More

Pharma-backed initiative delivers low-cost hep C drugs

 A new program run by charities and academia with the support of pharma is looking to cure 25,000 hep C patients in Africa and Southeast Asia by allowing better access to new drugs. The ministries of Health in Ethiopia, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam have all signed up to…

Read More

France to Provide Universal Hepatitis C Treatment by Fall 2016

June 10, 2016 After years of limitations, France is now offering immediate hepatitis C virus (HCV) treatment to every HCV-positive person diagnosed with at least stage 2 liver fibrosis in the country. France also plans to provide universal access to the lifesaving cures by September 2016, according to a recent…

Read More